Market Place
Sourcing Support
Passage Bio Shares Data From Uplift-D FTD-GRN Study
10 Jan 2025 //
GLOBENEWSWIRE
IGM, Y-mAbs, Passage Bio and more ring in 2025 with layoffs
10 Jan 2025 //
FIERCE BIOTECH
Passage Bio Reports Q3 2024 Financial Results & Business Highlights
13 Nov 2024 //
GLOBENEWSWIRE
Passage Bio to Present at Guggenheim Securities Health Conference
06 Nov 2024 //
GLOBENEWSWIRE
Passage Bio Presents Data For PBFT02 In FTD-GRN At ESGCT
24 Oct 2024 //
GLOBENEWSWIRE
Passage Bio To Present At Chardan Genetic Medicines Conference
23 Sep 2024 //
GLOBENEWSWIRE
Passage Bio To Present FTD-GRN Data At ISFTD2024
16 Sep 2024 //
GLOBENEWSWIRE
Passage Bio Welcomes Tom Kassberg to Board of Directors
10 Sep 2024 //
GLOBENEWSWIRE
Passage Bio To Present At H.C. Wainwright Investment Conference
30 Aug 2024 //
GLOBENEWSWIRE
Passage Bio Reports Q2 2024 Results And Recent Business Highlights
08 Aug 2024 //
GLOBENEWSWIRE
Passage Bio to Participate in Upcoming Investor Conferences
06 Aug 2024 //
GLOBENEWSWIRE
Passage Bio Out-Licenses Programs To GEMMA Biotherapeutics
01 Aug 2024 //
GLOBENEWSWIRE
Passage Bio Gets FDA Feedback On PBFT02 Trial Expansion To FTD-C9orf72
16 Jul 2024 //
GLOBENEWSWIRE
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
05 Jun 2024 //
GLOBENEWSWIRE
Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award
21 May 2024 //
GLOBENEWSWIRE
Passage Bio Reports Q1 2024 Results, Business Highlights
14 May 2024 //
GLOBENEWSWIRE
Passage Bio At Chardan Cell Therapy Summit
22 Apr 2024 //
GLOBENEWSWIRE
Passage Bio Seeks College Student Candidates for Scholarship Program
05 Mar 2024 //
GLOBENEWSWIRE
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results
04 Mar 2024 //
GLOBENEWSWIRE
Passage Bio to Participate in Upcoming Investor Conferences
27 Feb 2024 //
GLOBENEWSWIRE
Passage Bio to Present at 6th Annual Biotechnology Conference
31 Jan 2024 //
GLOBENEWSWIRE
Passage looks to offload lead program, 2 other assets
20 Dec 2023 //
FIERCE BIOTECH
Passage Bio Announces Promising Initial Data From Phase 1/2 Trial of PBFT02
20 Dec 2023 //
GLOBENEWSWIRE
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
17 Nov 2023 //
GLOBENEWSWIRE
Passage Bio Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Passage Bio to Present at Guggenheim™s 5th Annual Inflammation Conference
30 Oct 2023 //
GLOBENEWSWIRE
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20 Oct 2023 //
GLOBENEWSWIRE
Passage Bio to Present at Chardan™s 7th Annual Genetic Medicines Conference
25 Sep 2023 //
GLOBENEWSWIRE
Passage Bio Announces Promising Data with GM1 Gangliosidosis in Imagine-1 Study
07 Aug 2023 //
GLOBENEWSWIRE
Passage Bio Reports Second Quarter 2023 Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
Passage Bio to Participate in Upcoming Investor Conferences
01 Aug 2023 //
GLOBENEWSWIRE
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
31 Jul 2023 //
GLOBENEWSWIRE
Passage decides 26% staff, 2 execs not needed on clinical voyage
21 Jul 2023 //
FIERCE BIOTECH
Passage Bio lays off 26% of staff, leadership shuffle
20 Jul 2023 //
ENDPTS
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
05 Jun 2023 //
GLOBENEWSWIRE
Passage Bio Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Passage Bio Announces Recipient of Second Annual Tachi Yamada Scholarship Award
04 May 2023 //
GLOBENEWSWIRE
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 Apr 2023 //
GLOBENEWSWIRE
Passage Bio to Present at Chardanâ 7th Annual Genetic Medicines & Cell Therapy
17 Apr 2023 //
GLOBENEWSWIRE
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
06 Mar 2023 //
GLOBENEWSWIRE
Passage Bio Seeks Pennsylvania College Student Candidatesfor Scholarship Program
01 Mar 2023 //
GLOBENEWSWIRE
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
28 Feb 2023 //
GLOBENEWSWIRE
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results
27 Feb 2023 //
GLOBENEWSWIRE
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1
24 Feb 2023 //
GLOBENEWSWIRE
Passage Bio to Present Updated Data from Imagine-1 Study for GM1 Gangliosidosis
15 Feb 2023 //
GLOBENEWSWIRE
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 Jan 2023 //
GLOBENEWSWIRE
Passage of FDA Modernization Act 2.0 clears the way to reduce animal testing
03 Jan 2023 //
ENDPTS
Passage Bio gives look at first six patients in GM1 gangliosidosis trial
14 Dec 2022 //
ENDPTS
Passage Bio Announces Data from First Six Patients with GM1 Gangliosidosis
14 Dec 2022 //
GLOBENEWSWIRE
Passage Bio Reports Third Quarter 2022 Financial Results and Provides Updates
10 Nov 2022 //
GLOBENEWSWIRE
Passage Bio to Present at Guggenheim 4th Annual Immunology & Neurology Day
08 Nov 2022 //
GLOBENEWSWIRE
Passage Bio to Report Third Quarter 2022 Financial Results on November 10, 2022
03 Nov 2022 //
GLOBENEWSWIRE
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Oct 2022 //
GLOBENEWSWIRE
Passage Bio Announces Appointment of William Chou, M.D. as CEO
10 Oct 2022 //
GLOBENEWSWIRE
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
26 Sep 2022 //
GLOBENEWSWIRE
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
19 Aug 2022 //
GLOBENEWSWIRE
Passage Bio doses first subject in Phase I/II dementia gene trial
12 Aug 2022 //
CLINICALTRIALSARENA
Passage Bio Doses First Patient in Global Clinical Trial of PBFT02
11 Aug 2022 //
GLOBENEWSWIRE
Passage Bio to Present at 2022 Wedbush PacGrow Healthcare Virtual Conference
05 Aug 2022 //
GLOBENEWSWIRE
Passage Bio Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
